Android app Apple app link

Mural Oncology plc Ordinary Shares When Issued (MURAV) Financials

NASDAQ Currency in USD Disclaimer

$0.00

north_east NA Past Year
Day's range
$0
Day's range
$0

MURAV Income statement / Annual

Last year (2024), Mural Oncology plc Ordinary Shares When Issued's total revenue was $0.00, and the percentage change from the previous year is not available. In 2024, Mural Oncology plc Ordinary Shares When Issued's net income was -$128.51 M. See Mural Oncology plc Ordinary Shares When Issued,s key income statements, including revenue, expenses, profit, and income.

Period FY-2024
Period Ended 12/31/2024
Operating Revenue $0.00
Cost of Revenue $0.00
Gross Profit $0.00
Gross Profit Ratio 0
Research and Development Expenses $110.67 M
General & Administrative Expenses $27.60 M
Selling & Marketing Expenses $0.00
Selling, General & Administrative Expenses $27.60 M
Other Expenses $0.00
Operating Expenses $138.26 M
Cost And Expenses $0.00
Interest Income $0.00
Interest Expense $0.00
Depreciation & Amortization $0.00
EBITDA $0.00
EBITDA Ratio 0
Operating Income Ratio 0
Total Other Income/Expenses Net $0.00
Income Before Tax -$128.51 M
Income Before Tax Ratio 0
Income Tax Expense $0.00
Net Income -$128.51 M
Net Income Ratio 0
EPS -7.58
EPS Diluted -7.58
Weighted Average Shares Out $16.95 M
Weighted Average Shares Out Diluted $16.95 M
Link

Exclusive Content

Access to this content is reserved for premium members. Unlock all features by upgrading to a premium membership.

Get the App

To join as a premium member, please download our app and complete your membership purchase there.